TRPV2 and squamous cell carcinoma: It has been shown that urothelial carcinoma cells (Caprodossi et al., 2008; Mizuno et al., 2014), human leukemic cells (Pottosin et al., 2015), prostate cancer cells (Monet et al., 2010), esophagus squamous cell carcinoma cells (Zhou et al., 2014), and hepatocellular carcinoma cells (Liu et al., 2010) overexpress TRPV2 channels.